Texas OB/GYNs’ Limited Access to Medications for Miscarriage Management: New Brief

an ob-gyn is talking to a patient

A new Resound Research brief highlights barriers to accessing medications commonly used for miscarriage management, despite the fact that these safe, FDA-approved medications are legal. Researchers found that only 12% of physicians surveyed were able to prescribe and access mifepristone without difficulty. Although misoprostol is more widely available, fewer than half of respondents said they […]

New Brief: Thriving Texas Families Shows Gaps Between Program Goals and Activities

Texas landscape

The Thriving Texas Families (TTF) program is the largest alternatives-to-abortion initiative in the country. Our new analysis with the Center for Health Policy evaluates the program, finding gaps between spending, services, and stated goals — and offering evidence-based recommendations to strengthen outcomes. Our analysis shows: We recommend that the state invest in existing evidence-based state […]

Post-Dobbs Realities: Data Transparency and Trust in Maternal Health Care

Resound Research for Reproductive Health co-authored a new editorial in the American Journal of Public Health examining the ethical and public health implications of restricting maternal mortality data in the post-Dobbs era. In “Post-Dobbs Realities: Ethical Imperatives for Data Transparency and Trust in Maternal Health Care,” authors from the Center for Medical Ethics and Health […]

Effects of Time Constraints Under Texas’ 6-Week Abortion Ban

A new peer-reviewed study by Resound Research reveals how Texas’ SB8 law that prohibited abortion upon the detection of embryonic cardiac activity—commonly described as a “6-week abortion ban”—created compounded barriers for those seeking care.

Houston Chronicle Op-Ed

In a new op-ed for the Houston Chronicle, “Texas’ proposed abortion exceptions bill fails to recognize the complexities of pregnancy,” Dr. Kari White and Dr. Anitra Beasley discuss the limitations of Senate Bill 31.